Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q4 2020

Feb 16, 2021

SELL
$8.61 - $11.04 $920,408 - $1.18 Million
-106,900 Closed
0 $0
Q3 2020

Nov 16, 2020

BUY
$8.57 - $12.69 $916,133 - $1.36 Million
106,900 New
106,900 $963,000
Q1 2018

May 15, 2018

SELL
$16.68 - $22.07 $1.67 Million - $2.2 Million
-99,900 Closed
0 $0
Q3 2017

Nov 14, 2017

BUY
$15.41 - $32.17 $1.54 Million - $3.21 Million
99,900
99,900 $1.76 Million

Others Institutions Holding TEVA

About TEVA PHARMACEUTICAL INDUSTRIES LTD


  • Ticker TEVA
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,110,560,000
  • Market Cap $19.4B
  • Description
  • Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...
More about TEVA
Track This Portfolio

Track Capstone Investment Advisors, LLC Portfolio

Follow Capstone Investment Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capstone Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Capstone Investment Advisors, LLC with notifications on news.